AZD7762 | ≥99%(HPLC) | Selleck | Chk inhibitor
The Chk1/2 inhibitor AZD7762 sensitizes SW480 colon cancer cells to... | Download Scientific Diagram
DNA damage checkpoint kinases in cancer | Expert Reviews in Molecular Medicine | Cambridge Core
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine | Journal of Experimental & Clinical Cancer Research | Full Text
Combination Treatment of VE-821 and AZD7762 Results in S Phase Arrest... | Download Scientific Diagram
5 (3 Fluorophenyl) N (3 Piperidinyl) 3 Ureido 2 Thiophenecarboxamide - an overview | ScienceDirect Topics
AZD7762 | ≥99%(HPLC) | Selleck | Chk inhibitor
AZD-7762 | Chk Inhibitor | MedChemExpress
Effect of AR Knockdown and Chk1/2 Inhibitor AZD7762 on TopBP1-ATR-Chk1... | Download Scientific Diagram
Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide ( AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas | Journal of Medicinal Chemistry
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine | Journal of Experimental & Clinical Cancer Research | Full Text
AZD-7762 | Chk Inhibitor | MedChemExpress
CHK1 inhibitor AZD7762 alone caused more cytotoxicity to RBCC but... | Download Scientific Diagram
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours | SpringerLink
IJMS | Free Full-Text | Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development | HTML
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours | SpringerLink
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
Phase I Dose-escalation Study Of AZD7762, A Checkpoint Kinase Inhibitor, In Combination With Gemcitabine In Patients With Advanced Solid Tumors. | ApconiX
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy | Cell Death & Differentiation
Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer | Oncogene
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. - Abstract - Europe PMC
ATR Target Activation by the CHK1 Inhibitor AZD7762 in U2OS Cancer Cells | Download Scientific Diagram
Cells | Free Full-Text | DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives | HTML
Fig. S2). Treatment with AZD7762 alone resulted in a more rapid... | Download Scientific Diagram
